Liminatus Pharma Plunges 15.24% on Volatility Pause

On June 6, 2025, Liminatus Pharma experienced a significant drop of 15.24% in pre-market trading, marking a notable decline in its stock performance.

Trading of Liminatus Pharma was temporarily halted after the market opened due to a volatility trading pause. This regulatory measure is designed to stabilize stock prices and ensure orderly trading during periods of rapid price movements. Investors are advised to stay updated on the resumption of trading and subsequent market activity, as these pauses can significantly impact trading strategies and stock performance.

Liminatus Pharma's stock trading resumed after a brief halt, which was triggered by a volatility trading pause. This event highlights the importance of understanding market mechanics for making informed investment decisions during high volatility periods. The company's shares had previously surged following news of its compliance with Nasdaq regulations, indicating a positive response from investors to regulatory developments.